AAPL 184.1301
AMZN 125.465
BTC-USD 25815.7715
ETH-USD 1807.2111
EURUSD 1.072
TSLA 217.47

Overview Fundamentals API Earnings EOD API Sample Code Pricing

Supported exchanges /
US /
IMRX.US

Immuneering Corp (IMRX NASDAQ) stock market data APIs

$9.38 0.63(7.2%) as of June 2, 2023

Immuneering Corp Financial Data Overview

Prev. Close	8.75
Open	9.38
Volume	-
High	9.52
Low	8.45
52 wk Range	3.7-16.167
Market Cap	256 M
P/E Ratio
Shares Outstanding	29 249 K
Revenue	133 K
EPS	-0.51
Dividends (Yield)	0
Beta

Our easy-to-use no-coding solutions help you get the data effortlessly:

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Prices start at $19.99/month

General: {

Code: 'IMRX',

Type: 'Common Stock',

Name: 'Immuneering Corp',

Exchange: 'NASDAQ',

CurrencyCode: 'USD',

CurrencyName: 'US Dollar',

CurrencySymbol: '$',

CountryName: 'USA',

CountryISO: 'US',

OpenFigi: 'BBG009QXJQS1',

ISIN: NULL,

CUSIP: NULL,

CIK: '1790340',

EmployerIdNumber: NULL,

FiscalYearEnd: 'December',

IPODate: '2021-07-30',

InternationalDomestic: NULL,

Sector: 'Healthcare',

Industry: 'Biotechnology',

GicSector: NULL,

GicGroup: NULL,

GicIndustry: NULL,

GicSubIndustry: NULL,

HomeCategory: NULL,

IsDelisted: false,

}

Immuneering Corp Fundamental Data is available in our Financial Data APIs

Net Revenue 133 K
EBITDA -53 193 492
Earnings Per Share -2.44
Income Statements
Balance Sheets
Cash flows

Fundamental data package from $49.99 See full price

Get sample
of Fundamental API Data

Get Immuneering Corp Earnings via APIs

Latest Release 2023-05-04
EPS/Forecast -0.56

Calendar package from $19.99 See full price

Get sample
earnings calendar API

Get Immuneering Corp End-of-day Data via APIs

End of Day, Intraday and Live APIs
Splits
Dividends

All world package from $19.99 See full price

Get sample
of End-of-Day API Data

Get Immuneering Corp latest news via APIs

Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors

4 hours ago

- No dose limiting toxicities observed with IMM-1-104 up to 320 mg once daily during the Phase 1a dose escalation portion of ongoing clinical study - - Phase 1b dose expansion has commenced; plan to ...

CLINICAL STUDY
COLORECTAL
IMM-1-104
IMM-6-415
IMMUNEERING
IMMUNEERING CORPORATION
IMRX
NASDAQ:IMRX
ONCOLOGY
PANCREATIC
TARGETEDONCOLOGY
UNIVERSAL RAS

Immuneering to Present at the Jefferies Healthcare Conference

6 days ago

CAMBRIDGE, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an ini...

CALENDAR OF EVENTS
CANCER
CONFERENCE CALLS/ WEBCASTS
IMM-1-104
IMM-6-415
IMMUNEERING
IMMUNEERING CORPORATION
IMRX
NASDAQ:IMRX
ONCOLOGY
TARGETEDONCOLOGY
UNIVERSAL RAS

News API is available at any package from $19.99 See full price

Get sample of News API

Robust, powerful and easy to use

Our advantages

Prices start at
$19.99

Fast+ support 24/7 via web-chat and email

Robust, powerful and reliable data

One click API for all financial data you need

Sample code for your quick start

Ready-to-go solutions

Our easy-to-use no-coding solutions help you get the data directly to MS Excel and Google Sheets. Or download the CSV (TXT) files effortlessly with tools for Windows and Linux.

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

Best price for all data API

Prices start at $19.99/month

All-In-One

$79.99/per month

100 000+ API requests per day
EOD Data - All World Extended
Splits and Dividends
Fundamental Data
Bonds Data
Options Data
1000+ currency pairs
1000+ cryptocurrency pairs

Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com